Serum Androgen Profiles in Women with Premature Ovarian Insufficiency: a Systematic Review and Meta-analysis

Overview

Journal Menopause

Specialty Gynecology & Obstetrics

Date 2018 Jul 12

PMID 29994966

Citations 7

Authors

Midhun Soman

Li-Cong Huang

Wen-Hui Cai

Jun-Bi Xu

Jun-Yao Chen

Ren-Ke He

Heng-Chao Ruan

Xiang-Rong Xu

Zhi-Da Qian

Xiao-Ming Zhu

Affiliations

Soon will be listed here.

Abstract

Objective: This meta-analysis aims to investigate serum androgen profiles (testosterone, dehydroepiandrosterone sulfate, androstenedione, and sex hormone-binding globulin) in women with premature ovarian failure and to establish if there is evidence of diminished androgen levels in these women.

Methods: Various Internet sources of PubMed, Cochrane library, and Medline were searched systematically until February, 2018. Out of a pool of 2,461 studies, after applying the inclusion/exclusion criterion, 14, 8, 10, and 9 studies were chosen for testosterone, dehydroepiandrosterone sulfate, androstenedione, and sex hormone-binding globulin, respectively, for this meta-analysis. The effect measure was the standardized mean difference with 95% confidence interval (95% CI) in a random-effects model.

Results: The testosterone concentrations in premature ovarian insufficiency were compared with fertile controls: stamdard mean difference (IV, random, 95% CI) -0.73 [-0.99, -0.46], P value < 0.05. The dehydroepiandrosterone sulfate concentrations in premature ovarian insufficiency compared to fertile controls: standard mean difference (IV, random, 95% CI) -0.65 [-0.92, -0.37], P value < 0.05. Androstenedione in premature ovarian insufficiency were compared with fertile controls: standard mean difference (IV, random, 95% CI) -1.09 [-1.71, -0.48], P value < 0.05. Sex hormone-binding globulin levels did not show statistical significance. The dehydroepiandrosterone sulfate levels were reduced in premature ovarian insufficiency cases, but still showed a higher level than in postmenopausal women.

Conclusions: Women with premature ovarian insufficiency are at risk for decreased concentrations of testosterone, dehydroepiandrosterone sulfate, and androstenedione. Dehydroepiandrosterone sulfate levels were more reduced in postmenopausal controls when compared with premature ovarian insufficiency cases.

Citing Articles

Testosterone mediates life-history trade-offs in female mammals.

Crespi B, Bushell A, Dinsdale N Biol Rev Camb Philos Soc. 2024; 100(2):871-891.

PMID: 39542451 PMC: 11885704. DOI: 10.1111/brv.13166.

Age at Natural Menopause; A Data Mining Approach (Data from the National Health and Nutrition Examination Survey 2013-2014).

Alinia T, Khodakarim S, Ramezani Tehrani F, Sabour S Int J Prev Med. 2023; 12:180.

PMID: 37663399 PMC: 10472079. DOI: 10.4103/ijpvm.IJPVM_647_20.

Premature Ovarian Insufficiency.

Kapoor E Curr Opin Endocr Metab Res. 2023; 28.

PMID: 36936056 PMC: 10022589. DOI: 10.1016/j.coemr.2023.100435.

Prenatal Origins of Endometriosis Pathology and Pain: Reviewing the Evidence of a Role for Low Testosterone.

Crespi B, Evans S J Pain Res. 2023; 16:307-316.

PMID: 36762368 PMC: 9904225. DOI: 10.2147/JPR.S389166.

Autologous transplantation of thecal stem cells restores ovarian function in nonhuman primates.

Chen H, Xia K, Huang W, Li H, Wang C, Ma Y Cell Discov. 2021; 7(1):75.

PMID: 34462432 PMC: 8405815. DOI: 10.1038/s41421-021-00291-0.

References

Nelson L, Covington S, Rebar R . An update: spontaneous premature ovarian failure is not an early menopause. Fertil Steril. 2005; 83(5):1327-32. DOI: 10.1016/j.fertnstert.2004.11.059. View

Webber L, Davies M, Anderson R, Bartlett J, Braat D, Cartwright B . ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016; 31(5):926-37. DOI: 10.1093/humrep/dew027. View

Labrie F, Martel C, Belanger A, Pelletier G . Androgens in women are essentially made from DHEA in each peripheral tissue according to intracrinology. J Steroid Biochem Mol Biol. 2017; 168:9-18. DOI: 10.1016/j.jsbmb.2016.12.007. View

Welt C . Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol (Oxf). 2007; 68(4):499-509. DOI: 10.1111/j.1365-2265.2007.03073.x. View

Mason M, Fonseca E, Ruiz J, Moran C, Zarate A . Distribution of follicle-stimulating hormone and luteinizing hormone isoforms in sera from women with primary ovarian failure compared with that of normal reproductive and postmenopausal women. Fertil Steril. 1992; 58(1):60-5. DOI: 10.1016/s0015-0282(16)55137-1. View

Lu Q, Shen H, Li Y, Zhang C, Wang C, Chen X . Low testosterone levels in women with diminished ovarian reserve impair embryo implantation rate: a retrospective case-control study. J Assist Reprod Genet. 2014; 31(4):485-91. PMC: 3969473. DOI: 10.1007/s10815-014-0186-3. View

Ono Y, Tanabe A, Nakamura Y, Yamamoto H, Hayashi A, Tanaka T . A low-testosterone state associated with endometrioma leads to the apoptosis of granulosa cells. PLoS One. 2014; 9(12):e115618. PMC: 4275210. DOI: 10.1371/journal.pone.0115618. View

Tyagi V, Scordo M, Yoon R, Liporace F, Greene L . Revisiting the role of testosterone: Are we missing something?. Rev Urol. 2017; 19(1):16-24. PMC: 5434832. DOI: 10.3909/riu0716. View

Elias A, Pandian M, Rojas F . Serum levels of androstenedione, testosterone and dehydroepiandrosterone sulfate in patients with premature ovarian failure to age-matched menstruating controls. Gynecol Obstet Invest. 1997; 43(1):47-8. DOI: 10.1159/000291817. View

10.

Gleicher N, Kim A, Weghofer A, Kushnir V, Shohat-Tal A, Lazzaroni E . Hypoandrogenism in association with diminished functional ovarian reserve. Hum Reprod. 2013; 28(4):1084-91. DOI: 10.1093/humrep/det033. View

11.

Ryan J, Scali J, Carriere I, Amieva H, Rouaud O, Berr C . Impact of a premature menopause on cognitive function in later life. BJOG. 2014; 121(13):1729-39. DOI: 10.1111/1471-0528.12828. View

12.

Kalantaridou S, Calis K, Vanderhoof V, Bakalov V, Corrigan E, Troendle J . Testosterone deficiency in young women with 46,XX spontaneous premature ovarian failure. Fertil Steril. 2006; 86(5):1475-82. DOI: 10.1016/j.fertnstert.2006.04.028. View

13.

Burger H, Dudley E, Robertson D, Dennerstein L . Hormonal changes in the menopause transition. Recent Prog Horm Res. 2002; 57:257-75. DOI: 10.1210/rp.57.1.257. View

14.

Higgins J, Thompson S, Deeks J, Altman D . Measuring inconsistency in meta-analyses. BMJ. 2003; 327(7414):557-60. PMC: 192859. DOI: 10.1136/bmj.327.7414.557. View

15.

Burger H . Androgen production in women. Fertil Steril. 2002; 77 Suppl 4:S3-5. DOI: 10.1016/s0015-0282(02)02985-0. View

16.

Daan N, Jaspers L, Koster M, Broekmans F, de Rijke Y, Franco O . Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features. Hum Reprod. 2015; 30(10):2376-86. DOI: 10.1093/humrep/dev195. View

17.

Shohat-Tal A, Sen A, Barad D, Kushnir V, Gleicher N . Genetics of androgen metabolism in women with infertility and hypoandrogenism. Nat Rev Endocrinol. 2015; 11(7):429-41. DOI: 10.1038/nrendo.2015.64. View

18.

Rivera-Woll L, Papalia M, Davis S, Burger H . Androgen insufficiency in women: diagnostic and therapeutic implications. Hum Reprod Update. 2004; 10(5):421-32. DOI: 10.1093/humupd/dmh037. View

19.

Benetti-Pinto C, Bedone A, Magna L . Evaluation of serum androgen levels in women with premature ovarian failure. Fertil Steril. 2005; 83(2):508-10. DOI: 10.1016/j.fertnstert.2004.09.015. View

20.

Ates S, Yesil G, Sevket O, Molla T, Yildiz S . Comparison of metabolic profile and abdominal fat distribution between karyotypically normal women with premature ovarian insufficiency and age matched controls. Maturitas. 2014; 79(3):306-10. DOI: 10.1016/j.maturitas.2014.07.008. View